𝔖 Bobbio Scriptorium
✦   LIBER   ✦

4-(Arylamino)phenyl α-d-glucopyranosides as potential anti-HIV agents

✍ Scribed by Josie C. Briggs; Alan H. Haines


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
446 KB
Volume
282
Category
Article
ISSN
0008-6215

No coin nor oath required. For personal study only.

✦ Synopsis


Our recent interest in aryl-substituted phenyl C~-D-glucopyranosides as potential anti-HIV agents [I-3] led us to examine 4-(arylamino)phenyl a-o-glucopyranosides (1) in this context, since we regarded these glycosides as a logical modification of 4-(arylsulfonylamino)phenyl a-D-glucopyranosides (2), one of which had been shown [3] to possess weak anti-HIV activity against HIV-I ilIB in infected cell cultures. Glycosides of the type 2 were found [3] to be remarkably eflective competitive inhibitors of yeast ¢:e-t)-glucosidase, an observation of relevance in regard to .'mti-HIV activity since nojirimycin, castanosperlnine, and some of their deriwltives which show such antivirai activity also act competitively against certain glycosidases [4]. We now report the synthesis of a series of glycosides 3=6 and some representative examples of lipophilic O-acyl derivatives, compounds 711t), and results of anti.HIV tests with these compounds.


📜 SIMILAR VOLUMES


Synthesis and Studies of New 2-(Coumarin
✍ Dharmesh H. Mahajan; Christophe Pannecouque; Erik De Clercq; Kishor H. Chikhalia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 2 views

## Abstract Novel 2‐(coumarin‐4‐yloxy)‐4,6‐(substituted)‐s‐triazine derivatives __i. e.,__ diaryltriazine (DATA) are reported as novel non‐nucleoside reverse transcriptase inhibitors (NNRTIs), were synthesized and their activities against human immunodeficiency virus HIV‐1 (III‐B), HIV‐2 (ROD), and